Natural killer cells: a thriving frontier in allogeneic cell therapy
Kai Pinkernell, chief medical officer at Glycostem, discusses how natural killer (NK) cell therapies could…
September 27, 2022 - 6 minutes
Interview
Europe’s first lab-grown fish company Bluu Seafood is aiming for sustainability
Overfishing is a global issue that negatively impacts the ecosystem and our access to fish…
September 27, 2022 - 5 minutes
Rapid diagnostics are needed to tackle antimicrobial resistance
As the antimicrobial resistance (AMR) crisis grows, bacterial infections are becoming harder to treat. Chris…
September 26, 2022 - 5 minutes
Orchestrating the evolving cell therapy supply chain
In a few decades, the cell and gene therapy sector has diversified into many complex…
September 12, 2022 - 5 minutes
How CDMOs keep pace with trends in advanced therapies
Advanced therapies including cell and gene therapies are exploding in demand, but the manufacturing process…
August 31, 2022 - 8 minutes
Making a success out of technology transfer at UCLB
Having a good relationship with the technology transfer office at your university can be key…
August 29, 2022 - 13 minutes
Hiring practices are shifting as biotech goes digital
Cloud computing is becoming increasingly prevalent as demand for global collaborations grows. Sajith Wickramasekara, founder…
August 22, 2022 - 5 minutes
How re-engineering antibodies can prevent allergies
The California startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies…
August 19, 2022 - 9 minutes
Delaying menopause could slow the aging process
After decades of neglect, women’s health is attracting increasing interest in the biotech industry. The…
August 19, 2022 - 6 minutes
The challenges of developing radiopharmaceuticals for cancer
Radiopharmaceuticals have been a relatively niche area of cancer therapy for decades. Steffen Schuster, the…
August 17, 2022 - 5 minutes
How the UK precision breeding bill could unshackle gene editing
The U.K. is considering lowering restrictions on gene-edited crops. PacBio’s Neil Ward explains how the…
August 10, 2022 - 6 minutes
Finding investment opportunities in a bleak biotech stock market
The situation remains difficult in public markets as biotech stocks struggle to recover from a…
July 21, 2022 - 7 minutes
